Why the study?
Does modulation of adrenergic receptors reverse pathological remodeling and improve cardiac dysfunction in heart failure?
Does modulation of adrenergic receptors reverse pathological remodeling and improve cardiac dysfunction in heart failure?
Modulation of adrenergic receptors represents a promising future molecular approach to reverse pathological cardiac remodeling in heart failure based on recent animal studies.
Adrenergic receptor modulation remains investigational in heart failure; leaves open translation of animal remodeling data to clinical outcomes.
PURPOSE OF REVIEW: Heart failure is a common clinical syndrome, and despite intensive medical therapy it remains a leading cause of global morbidity and mortality. Pathological stimuli promote a general remodeling process in the heart. RECENT FINDINGS: Recent animal studies have highlighted very promising novel therapeutic possibilities, based on the regulation of adrenergic receptor function, and novel signaling pathways are being discovered that could be relevant for future molecular approaches. SUMMARY: This review highlights some of the novel approaches to reverse pathological remodeling and improve cardiac dysfunction, placing emphasis on strategies targeting the adrenergic receptors.
No takes yet. Share an insight, caveat, or question.
Perrino et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: